Biologically effective dose biomarkers;Indicatori di dose biologicamente efficace

Giornale Italiano di Medicina del Lavoro ed Ergonomia

Volumn 26, Issue 4, 2004, Pages 298-301

  Miraglia, N ^a   Assennato, G ^b   Clonfero, E ^c   Fustinoni, S ^d   Sannolo, N ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Biomarkers; DNA adducts; Hemoglobin adducts; Molecular dosimetry

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; XENOBIOTIC AGENT;

BIOLOGICAL MONITORING; CELL FUNCTION; CELL STRUCTURE; CONFERENCE PAPER; DIET; DNA ADDUCT; DOSIMETRY; OCCUPATIONAL EXPOSURE; SMOKING HABIT;

BIOLOGICAL MARKERS; CARCINOGENS, ENVIRONMENTAL; COSTS AND COST ANALYSIS; DIET; DNA ADDUCTS; ENVIRONMENTAL MONITORING; GENETIC MARKERS; HUMANS; MUTAGENS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RESEARCH; RISK FACTORS; SMOKING; XENOBIOTICS;

EID: 8544270908     PISSN: 15927830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. National Research Council, 1987. Biological Markers in Environmental Health Perspectives. 74: 1-191.
2. Toniolo P, Boffetta P, Shuker DEG, Rothman N, Hulka B, Pearce N. Workshop Report in Application of Biomarkers in Cancer Epidemiology. IARC Scientific Publications N. 142. International Agency for Research on Cancer, Lyon, 1997.
3. Perera FP 1995, Biomarkers and Occupational Health. Progress and Perspectives. ML. Mendelson, JP Peeters, MJ Normandy Editors, Joseph Henry Press, Washington, D.C. pp 105-108.
4. Perera FP. The significance of DNA and protein adducts in human biomonitoring studies. Mutat Res. 1988; 205(1-4): 255-69. Review.
5. Poirier MC, Santella RM, Weston A. Carcinogen macromolecular adducts and their measurement. Carcinogenesis. 2000; 21(3): 353-9.
6. Fustinoni S, Colosio C, Colombi A, Yoewell-O'Connell K, Rappaport SM. Albumin and hemoglobin adducts as biomarkers of exposure to styrene in fiberglass-reinforced-plastic workers. Int Arch Occup Environ Health 1998; 71: 185-190.
7. Fustinoni S, Soleo L, Warholm M, Begemann P, Rannug A, Neumann H-G, Swernberg JA, Vimercati L, Foà V, Colombi A. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidem Biomarkers Prevention 2002; 11: 1082-1090.
8. Dickey C, Santella RM, Hattis D, Tang D, Hsu Y, Cooper T, Young TL, Perera F. Variability in PAH-DNA Adduct Measurements in Peripheral Mononuclear Cells: Implications for Quantitative Cancer Risk Assessment. Risk Analysis 1997; 17(5): 649-56.
9. Tornqvist M, Fred C, Haglund J, Helleberg H, Paulsson B, Rydberg P. Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 778(1-2): 279-308.
10. Tornqvist M, Mowrer J, Jensen S, Ehrenberg L. Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal Biochem 1986; 154(1): 255-66.
11. Begemann P, Upton PB, Ranasinghe A, Swernberg JA, Soleo L, Vimercati L, Gelormini A, Fustinoni S, Zwirner-Baier I, Neumann H-G. Hemoglobin adducts as biomarkers of 1,3-butadiene in occupationally low exposed Italian workers and few diesel-exposed miners. Chem Bio Interct 2001; 135-136: 675-678.
12. Rappaport SM, Ting D, Jin Z, Yeowell-O'Connell K, Waidyanatha S, McDonald T. Application of Raney nickel to measure adducts of styrene oxide with hemoglobin and albumin. Chem Res Toxicol 1993; 6(2): 238-44.
13. Miraglia N, Genovese G, Acampora A, Malorni L, Sannolo N. A novel mass spectrometry technique for the evaluation of occupational exposure to methyl bromide. J Mass Spectrom 2002; 37: 1171-1174.
14. Basile A, Ferranti P, Pocsfalvi G, Miraglia N, Soleo L, Ambrosi L, Sannolo N, Malorni A. A novel approach for identification and measurement of hemoglobin adducts with 1,2,3,4-diepoxybutane by LC/ES/MS and tandem mass spectrometry. Rapid Commun Mass Spectrom 2001; 15: 527-540.
15. Miraglia N, Pocsfalvi G, Ferranti P, Basile A, Sannolo N, Acampora A, Soleo L, Palmieri F, Caira S, De Giulio B, Malorni A. Mass Spectrometry identification of a candidate biomarker peptide from the in vitro interaction of epichlorohydrin with red blood cells. J Mass Spectrom 2001; 36(1): 47-57.
16. Miraglia N, Pieri M, Basile A, Malorni L, Acampora A, Soleo L and Sannolo N. Exposure to genotoxic agents: modified peptides as suitable biomarkers. In: Recent Res. Develop. Peptides. Research Sign-post 2002; 1: 49-63.
17. Pearce N, de Sanjose S, Boffetta P, Kogevinas M, Saracci R, Savitz D. Limitations of Biomarkers of Exposure in Cancer Epidemiology. Epidemiology 1995; 6(2): 190-194.
18. Hayashi T, Ohe Y, Hayashi H, Iwai K. Human spleen histone H2A. Isolation and four variant sequences. J Biochem (Tokyo). 1980; 88(1): 27-34.
19. Commerford SL, Carsten AL, Cronkite EP. Histone turnover within nonproliferating cells. Proc Natl Acad Sci U S A. 1982; 79(4): 1163-5.
20. Albertini RJ 1995. Costs of developing a large-scale biomarker program to monitor cleanup workers. In Biomarkers and Occupational Health. Progress and Perspectives. ML. Mendelson, JP Peeters, MJ Normandy Editors, Joseph Henry Press, Washington, D.C. pp 70-88.